Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Cancer

Tools & Techniques Diagnostics & prognostics

All the RAGE

| Luke Turner

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Tools & Techniques Omics

A Microbial Map to Cancer

| Michael Schubert

A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.

Tools & Techniques Omics

Super Method Seeks Cancer's Kryptonite

| Jonathan James

The application of CRISPR on a genome-wide scale provides a major insight into tumor dependency.

Outside the Lab Public health

Picking up on the Subtler Signs of Brain Cancer

| Jonathan James

How early telltales of tumors are frequently missed by both patients and clinicians

Research Field Cancer

Cancer and the Microbiome

| Ivan Gladwyn-Ng, Alexander Maue

How advanced studies into the microorganisms we harbor could impact cancer prevention, treatment, and prognosis.

Research Field Nanomedicine

Rewriting the Cancer Code

| Jonathan James

Scientists are targeting cancer’s “housekeeping” genes with biological nanomachines

Disease Area Cancer

Proving the worth of ICIs

| Jonathan James

New evidence points to the safety – and benefits – of immune checkpoint therapy in HIV-positive cancer patients

Tools & Techniques Cancer

Circular RNA Makes Its Mark

| Jason Sherburn

A new detection method enhances circular RNA’s potential as a cancer biomarker and forms the basis of a new database

Tools & Techniques Diagnostics & prognostics

A Nose for Cancer

| Jonathan James

Could a multi-layer graphene (MLG)-based biomarker sensor offer the sensitivity needed for earlier lung cancer detection?

Disease Area Cancer

Two-pronged Attack on Neuroblastoma

| Jonathan James

How inhibiting both polyamine synthesis (with DFMO) and uptake (with new small molecule AMXT 1501) could delay tumor development.

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Sister Publications

You might be interested in our Sister Publications:

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register